EWS	O
-	O
FLI1	O
utilizes	O
divergent	O
chromatin	O
remodeling	O
mechanisms	O
to	O
directly	O
activate	O
or	O
repress	O
enhancer	O
elements	O
in	O
Ewing	O
sarcoma	O
.	O


The	O
aberrant	O
transcription	O
factor	O
EWS	O
-	O
FLI1	O
drives	O
Ewing	O
sarcoma	O
,	O
but	O
its	O
molecular	O
function	O
is	O
not	O
completely	O
understood	O
.	O


We	O
find	O
that	O
EWS	O
-	O
FLI1	O
reprograms	O
gene	O
regulatory	O
circuits	O
in	O
Ewing	O
sarcoma	O
by	O
directly	O
inducing	O
or	O
repressing	O
enhancers	O
.	O


At	O
GGAA	O
repeat	O
elements	O
,	O
which	O
lack	O
evolutionary	O
conservation	O
and	O
regulatory	O
potential	O
in	O
other	O
cell	O
types	O
,	O
EWS	O
-	O
FLI1	O
multimers	O
induce	O
chromatin	O
opening	O
and	O
create	O
de	O
novo	O
enhancers	O
that	O
physically	O
interact	O
with	O
target	O
promoters	O
.	O


Conversely	O
,	O
EWS	O
-	O
FLI1	O
inactivates	O
conserved	O
enhancers	O
containing	O
canonical	O
ETS	O
motifs	O
by	O
displacing	O
wild	O
-	O
type	O
ETS	O
transcription	O
factors	O
.	O


These	O
divergent	O
chromatin	O
-	O
remodeling	O
patterns	O
repress	O
tumor	O
suppressors	O
and	O
mesenchymal	B-TISSUE
lineage	E-TISSUE
regulators	O
while	O
activating	O
oncogenes	O
and	O
potential	O
therapeutic	O
targets	O
,	O
such	O
as	O
the	O
kinase	O
VRK1	O
.	O


Our	O
findings	O
demonstrate	O
how	O
EWS	O
-	O
FLI1	O
establishes	O
an	O
oncogenic	O
regulatory	O
program	O
governing	O
both	O
tumor	O
survival	O
and	O
differentiation	O
.	O
